ReviewNeurogenetics2026

CRISPR-Cas9-based therapies for Huntington's disease and Friedreich's ataxia: mechanisms, advances, and future perspectives.

Abha Ravikumar Mundada et al.PubMed ↗Publisher ↗

No numbers read from the abstract.